References
- Laddu D, Ma J, Kaar J, et al. Health behavior change programs in primary care and community practices for cardiovascular disease prevention and risk factor management among midlife and older adults: a scientific statement from the American Heart Association. Circulation. 2021;144(24):533–549. doi:10.1161/CIR.0000000000001026
- Bittencourt MS, Hulten E, Ghoshhajra B, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7(2):282–291. doi:10.1161/CIRCIMAGING.113.001047
- Lin CK, McDonough RJ, Prentice RL, et al. Assessment of major adverse cardiovascular events and ischemic stroke with coronary computed tomography angiography based upon angiographic diagnosis in a high-volume single center. SAGE Open Med. 2014;2(5):2050312114533535. doi:10.1177/2050312114533535
- Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–744. doi:10.1093/eurheartj/ehr331
- D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
- Hajifathalian K, Ueda P, Lu Y, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015;3(5):339–355. doi:10.1016/S2213-8587(15)00081-9
- Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi:10.1093/eurheartj/ehab484
- Cao G, Chen W, Pan K, et al. Reduced artifacts and improved diagnostic value of 640-slice computed tomography in patients with cardiac pacemakers. J Int Med Res. 2019;47(5):1916–1926. doi:10.1177/0300060519825986
- Mondal R, Ritu RB, Banik PC. Cardiovascular risk assessment among type-2 diabetic subjects in selected areas of Bangladesh: concordance among without cholesterol-based WHO/ISH, Globorisk, and Framingham risk prediction tools. Heliyon. 2021;7(8):e07728. doi:10.1016/j.heliyon.2021.e07728
- O’Connor SD, Graffy PM, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham risk score in predicting cardiovascular events in asymptomatic adults? Radiology. 2019;290(1):108–115. doi:10.1148/radiol.2018180562
- Ren H, Zhao L, Zou Y, et al. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus. Ren Fail. 2021;43(1):477–487. doi:10.1080/0886022X.2021.1893186
- Hadamitzky M, Täubert S, Deseive S, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34(42):3277–3285. doi:10.1093/eurheartj/eht293
- Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50(12):1161–1170. doi:10.1016/j.jacc.2007.03.067
- Czarnecki A, Qiu F, Elbaz-Greener G, et al. Variation in revascularization practice and outcomes in asymptomatic stable ischemic heart disease. JACC Cardiovasc Interv. 2019;12(3):232–241. doi:10.1016/j.jcin.2018.10.049
- Reynolds HR, Shaw LJ, Min JK, et al. Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity. Circulation. 2021;144(13):1024–1038. doi:10.1161/CIRCULATIONAHA.120.049755
- Gössl M, Faxon DP, Bell MR, et al. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv. 2012;5(4):597–604. doi:10.1161/CIRCINTERVENTIONS.111.965509